| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | SOX4 PRRX1 FOXQ1 HDX NPAS3 NSD1 POU2F1 GBX1 KCNIP3 CASZ1 MSGN1 CREBRF ZNF18 OLIG3 STOX2 ZSCAN10 GLI2 GLI3 ZNF358 ZFHX2 EN1 NEUROG2 LRRFIP1 FOXD4 | 5.24e-06 | 1459 | 120 | 24 | GO:0000977 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | SOX4 PRRX1 FOXQ1 FOXN4 HDX NPAS3 POU2F1 GBX1 KCNIP3 CASZ1 MSGN1 CREBRF ZNF18 OLIG3 ZSCAN10 GLI2 GLI3 ZNF358 ZFHX2 EN1 NEUROG2 LRRFIP1 FOXD4 | 1.00e-05 | 1412 | 120 | 23 | GO:0000981 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | SOX4 PRRX1 FOXQ1 FOXN4 HDX NSD1 POU2F1 KCNIP3 MSGN1 ZNF18 OLIG3 ZSCAN10 GLI2 GLI3 ZNF358 ZFHX2 EN1 NEUROG2 LRRFIP1 FOXD4 | 6.72e-05 | 1271 | 120 | 20 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | SOX4 PRRX1 FOXQ1 HDX NSD1 POU2F1 KCNIP3 MSGN1 ZNF18 OLIG3 ZSCAN10 GLI2 GLI3 ZNF358 ZFHX2 EN1 NEUROG2 LRRFIP1 FOXD4 | 1.54e-04 | 1244 | 120 | 19 | GO:0000978 |
| GeneOntologyMolecularFunction | calcium, potassium:sodium antiporter activity | 3.54e-04 | 5 | 120 | 2 | GO:0008273 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 5.90e-04 | 171 | 120 | 6 | GO:0015081 | |
| GeneOntologyBiologicalProcess | neuron fate commitment | 1.02e-06 | 91 | 120 | 7 | GO:0048663 | |
| GeneOntologyBiologicalProcess | ventral spinal cord development | 2.02e-05 | 57 | 120 | 5 | GO:0021517 | |
| GeneOntologyBiologicalProcess | spinal cord motor neuron cell fate specification | 3.06e-05 | 11 | 120 | 3 | GO:0021520 | |
| GeneOntologyBiologicalProcess | cell differentiation in spinal cord | 3.29e-05 | 63 | 120 | 5 | GO:0021515 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron fate commitment | 4.07e-05 | 12 | 120 | 3 | GO:0060579 | |
| GeneOntologyBiologicalProcess | cell fate commitment involved in pattern specification | 4.07e-05 | 12 | 120 | 3 | GO:0060581 | |
| GeneOntologyBiologicalProcess | ventral spinal cord interneuron differentiation | 6.67e-05 | 14 | 120 | 3 | GO:0021514 | |
| GeneOntologyBiologicalProcess | spinal cord development | 6.95e-05 | 119 | 120 | 6 | GO:0021510 | |
| GeneOntologyBiologicalProcess | sensory organ development | SOX4 PRRX1 FOXN4 POU2F1 PDZD7 CASZ1 MFSD2A OLIG3 CCM2 GLI2 GLI3 RP1L1 DCHS1 NEUROG2 | 8.93e-05 | 730 | 120 | 14 | GO:0007423 |
| GeneOntologyBiologicalProcess | spinal cord motor neuron differentiation | 9.34e-05 | 41 | 120 | 4 | GO:0021522 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord interneuron specification | 1.00e-04 | 3 | 120 | 2 | GO:0021775 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification | 1.00e-04 | 3 | 120 | 2 | GO:0021776 | |
| GeneOntologyBiologicalProcess | smoothened signaling pathway involved in ventral spinal cord patterning | 1.00e-04 | 3 | 120 | 2 | GO:0021910 | |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.81e-04 | 343 | 120 | 9 | GO:0090596 | |
| GeneOntologyBiologicalProcess | neural tube development | 1.82e-04 | 202 | 120 | 7 | GO:0021915 | |
| GeneOntologyBiologicalProcess | spinal cord dorsal/ventral patterning | 2.04e-04 | 20 | 120 | 3 | GO:0021513 | |
| GeneOntologyBiologicalProcess | developmental growth | AKAP6 AMH DISC1 INTS1 OSTN ARHGAP4 MFSD2A CCM2 BMP10 TRIM28 GLI2 GLI3 SMPD3 EN1 RAI1 | 2.64e-04 | 911 | 120 | 15 | GO:0048589 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | PRRX1 FOXN4 NSD1 POU2F1 TRIM71 TSC2 PDZD7 MSGN1 TRIM28 GLI2 GLI3 ZNF358 EN1 | 2.64e-04 | 713 | 120 | 13 | GO:0048598 |
| GeneOntologyBiologicalProcess | spinal cord patterning | 2.73e-04 | 22 | 120 | 3 | GO:0021511 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 2.82e-04 | 217 | 120 | 7 | GO:0021953 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | FOXQ1 FOXN4 TRIM71 TSC2 MSGN1 CCM2 BMP10 TRIM28 GLI2 GLI3 DCHS1 ASTN2 AJUBA | 4.28e-04 | 750 | 120 | 13 | GO:0048729 |
| GeneOntologyCellularComponent | GLI-SUFU complex | 1.98e-04 | 4 | 121 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | P-body | 3.18e-04 | 102 | 121 | 5 | GO:0000932 | |
| MousePheno | abnormal fear/anxiety-related behavior | SOX4 DCAF8 FOXN4 DISC1 DLGAP4 TMEM151B UBQLN4 HGSNAT NPAS3 TNRC6B GBX1 KCNIP3 ELFN2 CREBRF ZFHX2 C4A C4B AJUBA RAI1 ILKAP | 5.52e-06 | 919 | 99 | 20 | MP:0002065 |
| MousePheno | bowed radius | 6.71e-06 | 18 | 99 | 4 | MP:0004374 | |
| MousePheno | polyphalangy | 1.18e-05 | 7 | 99 | 3 | MP:0000413 | |
| MousePheno | abnormal hindbrain development | 2.09e-05 | 164 | 99 | 8 | MP:0006108 | |
| MousePheno | increased freezing behavior | 3.39e-05 | 128 | 99 | 7 | MP:0020421 | |
| MousePheno | short sternum | 4.91e-05 | 29 | 99 | 4 | MP:0004321 | |
| MousePheno | abnormal cerebellar foliation | 5.48e-05 | 58 | 99 | 5 | MP:0000857 | |
| MousePheno | abnormal cerebellum development | 6.00e-05 | 96 | 99 | 6 | MP:0000854 | |
| MousePheno | abnormal cerebellum lobule morphology | 1.26e-04 | 69 | 99 | 5 | MP:0009964 | |
| MousePheno | abnormal freezing behavior | 1.56e-04 | 163 | 99 | 7 | MP:0020420 | |
| MousePheno | small lung | 1.64e-04 | 115 | 99 | 6 | MP:0003641 | |
| MousePheno | lethality throughout fetal growth and development | SOX4 FOXQ1 POU2F1 TRIM71 TSC2 ADGRA2 BIRC6 CASZ1 BMP10 TACC3 RAI1 | 2.51e-04 | 435 | 99 | 11 | MP:0006208 |
| MousePheno | bowed tibia | 2.60e-04 | 18 | 99 | 3 | MP:0004358 | |
| MousePheno | abnormal neural tube morphology | SOX4 PRRX1 TRIM71 TSC2 ADGRA2 DENND1A MSGN1 ZNRF3 TRIM28 GLI2 GLI3 DCHS1 EN1 | 2.65e-04 | 591 | 99 | 13 | MP:0002151 |
| MousePheno | abnormal trachea morphology | 2.69e-04 | 81 | 99 | 5 | MP:0002282 | |
| MousePheno | enlarged cerebral aqueduct | 2.95e-04 | 4 | 99 | 2 | MP:0031442 | |
| MousePheno | increased inferior colliculus size | 2.95e-04 | 4 | 99 | 2 | MP:0000777 | |
| MousePheno | short ulna | 3.07e-04 | 46 | 99 | 4 | MP:0004359 | |
| MousePheno | decreased ulna size | 3.07e-04 | 46 | 99 | 4 | MP:0030900 | |
| MousePheno | abnormal neural tube closure | 3.40e-04 | 378 | 99 | 10 | MP:0003720 | |
| MousePheno | abnormal inferior colliculus morphology | 3.60e-04 | 20 | 99 | 3 | MP:0000776 | |
| MousePheno | reduced cerebellar foliation | 3.60e-04 | 20 | 99 | 3 | MP:0009719 | |
| MousePheno | short fibula | 3.60e-04 | 20 | 99 | 3 | MP:0002765 | |
| MousePheno | short humerus | 3.63e-04 | 48 | 99 | 4 | MP:0004351 | |
| MousePheno | abnormal nervous system development | SOX4 PRRX1 FOXQ1 MCIDAS NPAS3 TRIM71 TSC2 UBN2 ADGRA2 DENND1A MSGN1 OLIG3 ZNRF3 TRIM28 GLI2 GLI3 UNC5C DCHS1 EN1 NEUROG2 | 4.45e-04 | 1257 | 99 | 20 | MP:0003861 |
| MousePheno | abnormal fibula morphology | 4.58e-04 | 51 | 99 | 4 | MP:0002187 | |
| MousePheno | abnormal right lung accessory lobe morphology | 4.90e-04 | 5 | 99 | 2 | MP:0009571 | |
| MousePheno | increased forebrain size | 4.90e-04 | 5 | 99 | 2 | MP:0012139 | |
| MousePheno | abnormal eccrine sweat gland morphology | 4.90e-04 | 5 | 99 | 2 | MP:0000675 | |
| MousePheno | abnormal brain development | SOX4 FOXQ1 MCIDAS NPAS3 TRIM71 ADGRA2 DENND1A OLIG3 GLI2 GLI3 UNC5C EN1 NEUROG2 | 5.50e-04 | 638 | 99 | 13 | MP:0000913 |
| MousePheno | lethality throughout fetal growth and development, complete penetrance | 5.52e-04 | 263 | 99 | 8 | MP:0011099 | |
| MousePheno | abnormal facial morphology | PRRX1 FOXN4 TRIM71 UBN2 ADGRA2 EDA VWDE CCM2 MIDN GLI2 ACAN GLI3 RECQL4 SMPD3 TACC3 RAI1 | 6.24e-04 | 910 | 99 | 16 | MP:0003743 |
| MousePheno | abnormal limb long bone morphology | PRRX1 HGSNAT KCNIP3 ZSCAN10 GLI2 ACAN GLI3 RECQL4 BSCL2 SMPD3 EN1 RAI1 | 6.63e-04 | 568 | 99 | 12 | MP:0011504 |
| MousePheno | abnormal midbrain morphology | 7.06e-04 | 151 | 99 | 6 | MP:0000897 | |
| MousePheno | short tibia | 7.22e-04 | 274 | 99 | 8 | MP:0002764 | |
| Domain | Anaphylatoxin_comp_syst | 3.84e-04 | 5 | 117 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 3.84e-04 | 5 | 117 | 2 | IPR001840 | |
| Domain | K/Na/Ca-exchanger | 3.84e-04 | 5 | 117 | 2 | IPR004481 | |
| Domain | ANATO | 8.00e-04 | 7 | 117 | 2 | SM00104 | |
| Domain | ANATO | 8.00e-04 | 7 | 117 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 8.00e-04 | 7 | 117 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 8.00e-04 | 7 | 117 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 8.00e-04 | 7 | 117 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 1.06e-03 | 8 | 117 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 1.06e-03 | 8 | 117 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 1.06e-03 | 8 | 117 | 2 | IPR019742 | |
| Domain | NaCa_Exmemb | 1.36e-03 | 9 | 117 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 1.36e-03 | 9 | 117 | 2 | PF01699 | |
| Domain | A2M_N | 1.69e-03 | 10 | 117 | 2 | PF01835 | |
| Domain | A2M_N | 1.69e-03 | 10 | 117 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 1.69e-03 | 10 | 117 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 1.69e-03 | 10 | 117 | 2 | PS00477 | |
| Domain | A2M | 1.69e-03 | 10 | 117 | 2 | PF00207 | |
| Domain | A2M_N_2 | 1.69e-03 | 10 | 117 | 2 | IPR011625 | |
| Domain | A2M_comp | 1.69e-03 | 10 | 117 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 1.69e-03 | 10 | 117 | 2 | PF07703 | |
| Domain | A2M_recep | 1.69e-03 | 10 | 117 | 2 | PF07677 | |
| Domain | A2M_comp | 1.69e-03 | 10 | 117 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 1.69e-03 | 10 | 117 | 2 | IPR001599 | |
| Domain | TF_fork_head_CS_2 | 2.99e-03 | 46 | 117 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 3.18e-03 | 47 | 117 | 3 | IPR018122 | |
| Domain | Homeobox | 3.57e-03 | 234 | 117 | 6 | PF00046 | |
| Domain | FH | 3.58e-03 | 49 | 117 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 3.58e-03 | 49 | 117 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 3.58e-03 | 49 | 117 | 3 | PS00658 | |
| Domain | Fork_head_dom | 3.58e-03 | 49 | 117 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 3.58e-03 | 49 | 117 | 3 | PS50039 | |
| Domain | Forkhead | 3.58e-03 | 49 | 117 | 3 | PF00250 | |
| Domain | HOMEOBOX_1 | 3.73e-03 | 236 | 117 | 6 | PS00027 | |
| Domain | HOX | 3.80e-03 | 237 | 117 | 6 | SM00389 | |
| Domain | HOMEOBOX_2 | 3.96e-03 | 239 | 117 | 6 | PS50071 | |
| Domain | Homeobox_dom | 3.96e-03 | 239 | 117 | 6 | IPR001356 | |
| Domain | - | 4.91e-03 | 109 | 117 | 4 | 4.10.280.10 | |
| Domain | C345C | 4.98e-03 | 17 | 117 | 2 | SM00643 | |
| Domain | TNF_1 | 4.98e-03 | 17 | 117 | 2 | PS00251 | |
| Domain | HLH | 5.24e-03 | 111 | 117 | 4 | PF00010 | |
| Domain | TNF | 5.58e-03 | 18 | 117 | 2 | SM00207 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 5.58e-03 | 18 | 117 | 2 | IPR008930 | |
| Domain | HLH | 6.11e-03 | 116 | 117 | 4 | SM00353 | |
| Domain | TNF | 6.21e-03 | 19 | 117 | 2 | PF00229 | |
| Domain | TNF_dom | 6.21e-03 | 19 | 117 | 2 | IPR006052 | |
| Domain | NTR | 6.21e-03 | 19 | 117 | 2 | PF01759 | |
| Domain | TNF_2 | 6.21e-03 | 19 | 117 | 2 | PS50049 | |
| Domain | Netrin_module_non-TIMP | 6.21e-03 | 19 | 117 | 2 | IPR018933 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SOX4 TRPM4 MEX3D INTS1 HECTD4 NSD1 TSC2 SFI1 GRIN2D EDC4 ADGRA2 BIRC6 DENND1A CASZ1 NADSYN1 PWWP2B AATK ZNRF3 TRIM28 KANK3 ARHGAP33 RAI1 | 3.51e-11 | 1105 | 121 | 22 | 35748872 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | SOX4 PRRX1 FOXQ1 FOXN4 HDX NPAS3 POU2F1 GBX1 MSGN1 CREBRF OLIG3 GLI2 GLI3 ZFHX2 EN1 NEUROG2 FOXD4 | 1.83e-08 | 908 | 121 | 17 | 19274049 |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 9027508 | ||
| Pubmed | SOX4 PRRX1 FOXN4 NPAS3 POU2F1 BIRC6 OLIG3 TRIM28 GLI2 GLI3 ZNF358 ZFHX2 TACC3 FOXD4 | 1.92e-07 | 709 | 121 | 14 | 22988430 | |
| Pubmed | UBAP2 DLGAP4 HECTD4 NSD1 TNRC6B TSC2 GRIN2D EDC4 UBN2 STOX2 TRIM28 ATF7IP DCHS1 TACC3 RAI1 LRRFIP1 | 2.50e-07 | 963 | 121 | 16 | 28671696 | |
| Pubmed | AKAP6 CERK ZNF609 UBAP2 HECTD4 SFI1 ADGRA2 ARHGAP4 STOX2 AMOTL2 RAI1 | 2.57e-06 | 529 | 121 | 11 | 14621295 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | ZNF609 UBAP2 AFTPH DISC1 TMEM151B ZNF469 AATK GLI2 AJUBA LRRFIP1 | 2.81e-06 | 430 | 121 | 10 | 35044719 |
| Pubmed | 4.84e-06 | 10 | 121 | 3 | 9247260 | ||
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 21337666 | ||
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 21093585 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 1.20e-05 | 2 | 121 | 2 | 16565498 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15998580 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 1.20e-05 | 2 | 121 | 2 | 7373044 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 1.20e-05 | 2 | 121 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 1.20e-05 | 2 | 121 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 1.20e-05 | 2 | 121 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 1.20e-05 | 2 | 121 | 2 | 19933335 | |
| Pubmed | TACC3-TSC2 maintains nuclear envelope structure and controls cell division. | 1.20e-05 | 2 | 121 | 2 | 20237422 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 1.20e-05 | 2 | 121 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 1.20e-05 | 2 | 121 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 1.20e-05 | 2 | 121 | 2 | 15787745 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12207352 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30026462 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 1.20e-05 | 2 | 121 | 2 | 27758680 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 1.20e-05 | 2 | 121 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 1.20e-05 | 2 | 121 | 2 | 20506482 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12480675 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 1.20e-05 | 2 | 121 | 2 | 23749435 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23918728 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 1.20e-05 | 2 | 121 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 1.20e-05 | 2 | 121 | 2 | 3037333 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 11726230 | ||
| Pubmed | Normal exon copy number of the GLI2 and GLI3 genes in patients with esophageal atresia. | 1.20e-05 | 2 | 121 | 2 | 23442119 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 1.20e-05 | 2 | 121 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 1.20e-05 | 2 | 121 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 1.20e-05 | 2 | 121 | 2 | 2997024 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 1.20e-05 | 2 | 121 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 1.20e-05 | 2 | 121 | 2 | 8428773 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21857912 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24638111 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 1.20e-05 | 2 | 121 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 1.20e-05 | 2 | 121 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 1.20e-05 | 2 | 121 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 1.20e-05 | 2 | 121 | 2 | 3167981 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17283082 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 7545960 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 30041577 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 2572548 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 1.20e-05 | 2 | 121 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 1.20e-05 | 2 | 121 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 1.20e-05 | 2 | 121 | 2 | 18360261 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 22151770 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34051020 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 1.20e-05 | 2 | 121 | 2 | 18091514 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29080553 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 1.20e-05 | 2 | 121 | 2 | 26814963 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 1.20e-05 | 2 | 121 | 2 | 25339671 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17728371 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 6149580 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 6149581 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10693670 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12115608 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 3542363 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 2387317 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8132550 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 2395880 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26814708 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 6192448 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 6167582 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 16908004 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 1.20e-05 | 2 | 121 | 2 | 1438267 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 7365238 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 19150565 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 7391573 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17506029 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 17971360 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23715124 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 3464002 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 1.20e-05 | 2 | 121 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 1.20e-05 | 2 | 121 | 2 | 17971229 | |
| Pubmed | Adult Gli2+/-;Gli3Δ699/+ Male and Female Mice Display a Spectrum of Genital Malformation. | 1.20e-05 | 2 | 121 | 2 | 27814383 | |
| Pubmed | Linkage relations of dumpy, a recessive mutant on chromosome 13 of the mouse. | 1.20e-05 | 2 | 121 | 2 | 7328306 | |
| Pubmed | SOX4-induced upregulation of ARHGAP9 promotes the progression of acute myeloid leukemia. | 1.20e-05 | 2 | 121 | 2 | 34159626 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10662833 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 6881182 | ||
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 1.20e-05 | 2 | 121 | 2 | 3944109 | |
| Pubmed | Differential effects of GLI2 and GLI3 in regulating cervical cancer malignancy in vitro and in vivo. | 1.20e-05 | 2 | 121 | 2 | 29967343 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20154143 | ||
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 1.20e-05 | 2 | 121 | 2 | 17921792 | |
| Interaction | SUFU interactions | 3.52e-06 | 106 | 121 | 7 | int:SUFU | |
| Interaction | TOP3B interactions | SOX4 TRPM4 UBAP2 MEX3D INTS1 HECTD4 NSD1 TNRC6B TSC2 SFI1 GRIN2D EDC4 ADGRA2 BIRC6 DENND1A CASZ1 NADSYN1 PWWP2B AATK ZNRF3 TRIM28 KANK3 ARHGAP33 RAI1 | 5.91e-06 | 1470 | 121 | 24 | int:TOP3B |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 7.17e-04 | 9 | 82 | 2 | 1234 | |
| GeneFamily | Forkhead boxes | 9.74e-04 | 43 | 82 | 3 | 508 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.39e-03 | 181 | 82 | 5 | 694 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 1.51e-03 | 50 | 82 | 3 | 721 | |
| GeneFamily | CD molecules|Endogenous ligands|Tumor necrosis factor superfamily|Death inducing signaling complex | 2.97e-03 | 18 | 82 | 2 | 781 | |
| GeneFamily | PWWP domain containing | 4.43e-03 | 22 | 82 | 2 | 1147 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 4.83e-03 | 23 | 82 | 2 | 523 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 5.16e-03 | 718 | 82 | 9 | 28 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 5.96e-07 | 210 | 121 | 9 | M2010 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 7.84e-07 | 217 | 121 | 9 | MM861 | |
| Coexpression | ESC_V6.5_UP_EARLY.V1_UP | 1.24e-05 | 166 | 121 | 7 | M2770 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL15A1 FOXQ1 SGTB NPAS3 ADGRA2 STOX2 GLI3 KANK3 UNC5C SNX18 DCHS1 | 2.31e-05 | 505 | 121 | 11 | M39167 |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-Neutrophils|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-07 | 153 | 121 | 7 | c4dcdcaa672929c1da870e9fb8ada1bb030ad12f | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.11e-07 | 187 | 121 | 7 | 8e8b147258982b359447add5027318f5b6d51963 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 1.27e-06 | 200 | 121 | 7 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.74e-06 | 90 | 121 | 5 | a0baaf2b3cf07d457f0d242fc213689cba6fd449 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.74e-06 | 90 | 121 | 5 | ab4b08c6ac8695b38f841c0ecf2bb2c032111d04 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-06 | 163 | 121 | 6 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.62e-06 | 163 | 121 | 6 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.15e-06 | 170 | 121 | 6 | b1a16600754e0c12f7d39c9221f1b03135833f16 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 183 | 121 | 6 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 184 | 121 | 6 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.19e-05 | 186 | 121 | 6 | 1e6526fc9e9381b7ace864588cc7bd80194338d6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-05 | 188 | 121 | 6 | c9270517e6940e9793586f67f02431210552f278 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 192 | 121 | 6 | bfab13793e54de2550ee171397f7ece0625cdb4a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-05 | 192 | 121 | 6 | b54b0d5b88139905521c8d5d58332e89c08d589c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.75e-05 | 199 | 121 | 6 | c7d6a8398f2419b726a0461585d1ee0561654e3b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.75e-05 | 199 | 121 | 6 | 85b3b1ad01368dae4adbc9da7efc148e49992f69 | |
| ToppCell | NS-critical-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.18e-05 | 141 | 121 | 5 | 33ad925ff7be3c682741a6328216a89f9d4033e9 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.61e-05 | 150 | 121 | 5 | 70ac8ae4b1683fb17278a8e4606f2fa0b94988c0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 159 | 121 | 5 | c960df9e4fa980401941866b5081facac4590b4d | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 8.08e-05 | 162 | 121 | 5 | 91ac35ae7fde411cd6a44e715a33dac62419cab8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC1-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.06e-05 | 166 | 121 | 5 | c8a7d94ed762e5e045ab5f74eef691ddc5f74993 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 9.59e-05 | 168 | 121 | 5 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.86e-05 | 169 | 121 | 5 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 90 | 121 | 4 | 6adc78899a08d48da8ed4618ecf866c9ed9be059 | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 90 | 121 | 4 | a74f8172780adc1410e36e2718412010ee0ebf1f | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 90 | 121 | 4 | 909ad62d175b657d8e541b0981ce8fed0ba7ed6c | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.06e-04 | 90 | 121 | 4 | 936c5078677ec934f3049d8aa5a14d930aa2e6dc | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 175 | 121 | 5 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.16e-04 | 175 | 121 | 5 | b30589ff9dc18e745afe61f289e6d576c9c6c6b2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 175 | 121 | 5 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 175 | 121 | 5 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.22e-04 | 177 | 121 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 178 | 121 | 5 | 6bef4ef48f649c6e38ae732bc08e6d7814db588b | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.39e-04 | 182 | 121 | 5 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 183 | 121 | 5 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 184 | 121 | 5 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Ptgfr_(Postsubiculum)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.48e-04 | 98 | 121 | 4 | 9865a9de11dea6db0b75dd04fee523cd2da44766 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.51e-04 | 185 | 121 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-04 | 188 | 121 | 5 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.62e-04 | 188 | 121 | 5 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.62e-04 | 188 | 121 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 1.62e-04 | 188 | 121 | 5 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 189 | 121 | 5 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 189 | 121 | 5 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 189 | 121 | 5 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-04 | 189 | 121 | 5 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-04 | 190 | 121 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-04 | 190 | 121 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.75e-04 | 191 | 121 | 5 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 191 | 121 | 5 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 191 | 121 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.75e-04 | 191 | 121 | 5 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-04 | 192 | 121 | 5 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-04 | 192 | 121 | 5 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.79e-04 | 192 | 121 | 5 | d0649410cf5eacdb0c1dce70e37c7473ef5fddfa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 193 | 121 | 5 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 1.83e-04 | 193 | 121 | 5 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.83e-04 | 193 | 121 | 5 | e5016959f24370579a8770787e96869f264cf7b3 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 193 | 121 | 5 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 194 | 121 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 194 | 121 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-04 | 195 | 121 | 5 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.92e-04 | 195 | 121 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-04 | 196 | 121 | 5 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.97e-04 | 196 | 121 | 5 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 196 | 121 | 5 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.97e-04 | 196 | 121 | 5 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-04 | 196 | 121 | 5 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-04 | 196 | 121 | 5 | dbf154b3d166ffd07be717dac8d8a3350ac63e16 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.97e-04 | 196 | 121 | 5 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-04 | 106 | 121 | 4 | ede8407ad253080d1fa2a6e2aacf549ce220309a | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.02e-04 | 197 | 121 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 2.06e-04 | 198 | 121 | 5 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | 18-Airway|18 / Age, Tissue, Lineage and Cell class | 2.06e-04 | 198 | 121 | 5 | 3cdfcc6445858c3c54058bbd90b20b88b1771cca | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 198 | 121 | 5 | cc2b5b632e73e44bb60050f0db10d8f0dbb859fa | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 198 | 121 | 5 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-04 | 198 | 121 | 5 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 2.06e-04 | 198 | 121 | 5 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-04 | 199 | 121 | 5 | d65ee89d5c7e8ed693d58e6a6de09565840e11c5 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.11e-04 | 199 | 121 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.11e-04 | 199 | 121 | 5 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.11e-04 | 199 | 121 | 5 | 0602e2b2aa56d106da63bd342a38bef437b4d496 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.11e-04 | 199 | 121 | 5 | bf138cc692df727e087d140c014149ee5da00d9d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.11e-04 | 199 | 121 | 5 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | Severe-B_intermediate-0|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.16e-04 | 200 | 121 | 5 | da37ca52b0121ab0fb6ae69626de51350e979a6a | |
| ToppCell | (09)_Ionocytes-(3)_72hpi|(09)_Ionocytes / shred by cell type and Timepoint | 2.31e-04 | 110 | 121 | 4 | fce7d5a0617fc664b657f5bb9abb290e7cc234cb | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 9.51e-07 | 195 | 120 | 9 | 4124_UP | |
| Drug | celastrol; Down 200; 2.5uM; MCF7; HT_HG-U133A_EA | 6.84e-06 | 187 | 120 | 8 | 887_DN | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.04e-05 | 198 | 120 | 8 | 3929_UP | |
| Disease | mean arterial pressure, alcohol drinking | 4.37e-05 | 98 | 116 | 5 | EFO_0004329, EFO_0006340 | |
| Disease | 1,5 anhydroglucitol measurement | 2.01e-04 | 29 | 116 | 3 | EFO_0008009 | |
| Disease | Profound Mental Retardation | 2.28e-04 | 139 | 116 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 2.28e-04 | 139 | 116 | 5 | C0025363 | |
| Disease | Mental deficiency | 2.28e-04 | 139 | 116 | 5 | C0917816 | |
| Disease | hippocampal CA3 volume | 3.85e-04 | 36 | 116 | 3 | EFO_0009395 | |
| Disease | Intellectual Disability | 3.98e-04 | 447 | 116 | 8 | C3714756 | |
| Disease | body weight | AKAP6 PTBP3 HDX HECTD4 TNRC6B POLR1G SPATA31C1 DENND1A NBAS AATK SLC24A2 ACAN ASTN2 SMPD3 | 4.38e-04 | 1261 | 116 | 14 | EFO_0004338 |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 5.42e-04 | 9 | 116 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | Holoprosencephaly sequence | 6.75e-04 | 10 | 116 | 2 | cv:C0079541 | |
| Disease | PR interval | 7.75e-04 | 495 | 116 | 8 | EFO_0004462 | |
| Disease | coffee consumption measurement | 7.80e-04 | 182 | 116 | 5 | EFO_0006781 | |
| Disease | cortical surface area measurement | OSTN NPAS3 TNRC6B TRIM71 ADGRA2 DENND1A ZNF469 GLI3 RP1L1 UNC5C ASTN2 TACC3 AJUBA NEUROG2 | 8.24e-04 | 1345 | 116 | 14 | EFO_0010736 |
| Disease | systolic blood pressure, alcohol consumption measurement | 8.46e-04 | 47 | 116 | 3 | EFO_0006335, EFO_0007878 | |
| Disease | mean arterial pressure, alcohol consumption measurement | 1.14e-03 | 52 | 116 | 3 | EFO_0006340, EFO_0007878 | |
| Disease | diastolic blood pressure, alcohol consumption measurement | 1.27e-03 | 54 | 116 | 3 | EFO_0006336, EFO_0007878 | |
| Disease | cup-to-disc ratio measurement | 1.59e-03 | 430 | 116 | 7 | EFO_0006939 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 1.64e-03 | 59 | 116 | 3 | EFO_0001663, MONDO_0005148 | |
| Disease | systolic blood pressure, alcohol drinking | 1.66e-03 | 128 | 116 | 4 | EFO_0004329, EFO_0006335 | |
| Disease | polycystic ovary syndrome | 1.72e-03 | 60 | 116 | 3 | EFO_0000660 | |
| Disease | age-related hearing impairment | 1.81e-03 | 324 | 116 | 6 | EFO_0005782 | |
| Disease | Uterine leiomyoma, estrogen-receptor positive breast cancer | 2.25e-03 | 18 | 116 | 2 | EFO_1000649, HP_0000131 | |
| Disease | anti-Mullerian hormone measurement | 2.78e-03 | 20 | 116 | 2 | EFO_0004769 | |
| Disease | gait measurement | 2.96e-03 | 150 | 116 | 4 | EFO_0007680 | |
| Disease | neuroimaging measurement | UBAP2 OSTN TNRC6B DENND1A ZNF469 CCM2 ZNRF3 GLI3 TACC3 NEUROG2 RAI1 | 3.30e-03 | 1069 | 116 | 11 | EFO_0004346 |
| Disease | Paroxysmal atrial fibrillation | 3.40e-03 | 156 | 116 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.40e-03 | 156 | 116 | 4 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.40e-03 | 156 | 116 | 4 | C2585653 | |
| Disease | axial length measurement | 3.50e-03 | 77 | 116 | 3 | EFO_0005318 | |
| Disease | atrial fibrillation | 3.53e-03 | 371 | 116 | 6 | EFO_0000275 | |
| Disease | Immunologic Deficiency Syndromes | 3.67e-03 | 23 | 116 | 2 | C0021051 | |
| Disease | Atrial Fibrillation | 3.72e-03 | 160 | 116 | 4 | C0004238 | |
| Disease | Autistic Disorder | 3.77e-03 | 261 | 116 | 5 | C0004352 | |
| Disease | lean body mass | 3.92e-03 | 379 | 116 | 6 | EFO_0004995 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSGGSPELSALRLSE | 536 | Q9Y2J4 | |
| GGDSSIELEPGLSSS | 16 | Q4G0N7 | |
| AQSGGLEASGSLESP | 706 | A0A096LP49 | |
| SQSPTGTDDSLLGGL | 2606 | Q9NR09 | |
| LDTLGSEGALSPGGV | 986 | P0C0L5 | |
| GSGPLLSDSGSLLAT | 981 | Q96PE1 | |
| GGAAGALELLSSESG | 1206 | Q96PE1 | |
| SSPRGSLLLDGAGAG | 136 | Q96IF1 | |
| GTPSLLGAVSSGSAA | 816 | Q86V15 | |
| SGLTNPLDASGGSTL | 811 | Q6ULP2 | |
| EGPGSLAAGESSSLS | 306 | Q8IUR6 | |
| GLSAGSLSESAVGPV | 176 | Q9BSQ5 | |
| LPAGAITGDSGGELS | 6 | Q9BR61 | |
| SSSSLDPSLAGCGGD | 301 | Q9NRI5 | |
| LDGEAGAFRSSGPAS | 211 | Q9Y2H0 | |
| GSPGSAGTAAESRLL | 106 | O75129 | |
| SLDAAGASLATLPGG | 1641 | Q7Z5J4 | |
| SGGDSALSGELSASL | 981 | Q96L73 | |
| ALSRGFGSSAPEGLE | 751 | Q6P2E9 | |
| LEDGLGSSDSPGLLS | 11 | A6NI15 | |
| AGTAGAFLLEPSSGE | 1896 | Q96JQ0 | |
| SGLELPLTDGGSIGD | 726 | P10071 | |
| PLTDGGSIGDLSAID | 731 | P10071 | |
| ESGSLSALTPGEEAG | 516 | Q7Z353 | |
| LPGLSFGSEGDSDGK | 591 | Q2Q1W2 | |
| LLSPGGASAALSSSG | 191 | Q9H2A3 | |
| AAGGSAPELFTSLIG | 501 | O60721 | |
| ADGGSLEAVRLGPSS | 1601 | Q8N201 | |
| GSEPLSSDLGSLHGL | 496 | Q1X8D7 | |
| PLGLGDLSSGSLSSL | 11 | Q9H5P4 | |
| LSLSLTGDDGGPNRT | 46 | Q5TAQ9 | |
| AFAGLSEAPDGGSSR | 6 | Q9H7Z3 | |
| ATAGLRGDTALGAPS | 386 | Q86XN8 | |
| ELGTSGALLLPGASS | 36 | Q96LR2 | |
| TGPGSLGDLTALDDT | 686 | P10070 | |
| LVALGGDSNGSSSPL | 56 | P03971 | |
| GELSLTLTALDGGSP | 206 | Q9UN67 | |
| TGSLGSLGSLGEPLD | 3121 | Q9Y4D8 | |
| DGDSGSLGSPSASRE | 286 | Q9NY59 | |
| VAEGSGLTSLAAPLG | 401 | Q12950 | |
| GLTSLAAPLGGEGTS | 406 | Q12950 | |
| LGAAAAATPGGLSLS | 16 | Q05925 | |
| SALSGGSADLGGPRD | 2046 | A2RRP1 | |
| LDSRLASGGPSEGIS | 241 | Q9NQS5 | |
| SSLLGSDAPPGGDLA | 86 | D6RGH6 | |
| GGALSSGNASSPLSA | 186 | Q7RTU3 | |
| DFSGQLSGDRASGLP | 881 | P16112 | |
| LSGDRASGLPSGDLD | 886 | P16112 | |
| ASGLPSGDLDSSGLT | 891 | P16112 | |
| ELPSGAEILEGSASG | 936 | P16112 | |
| SASGVGDLSGLPSGE | 966 | P16112 | |
| EISASGFGDLSGLPS | 1536 | P16112 | |
| LSGLPSGREGLETSA | 1566 | P16112 | |
| ISGAGEISGLPSSEL | 1686 | P16112 | |
| DISGRASGLPSGTEL | 1701 | P16112 | |
| GSVELSGLPSGEADL | 1851 | P16112 | |
| ALASGGSLPITSLDA | 641 | P14859 | |
| GFGSPLDRLSAGSVD | 86 | P61366 | |
| GAESGSAAGLLPTSI | 6 | Q8NA29 | |
| SSPAASLGSQGSGLE | 61 | P12034 | |
| SESSAAGLGALSGSP | 696 | O14559 | |
| TSGTLSSLGGLDPDS | 86 | Q92838 | |
| GSLLDVATSPAGTSG | 1141 | Q711Q0 | |
| DGFLDSSAGGPGALL | 216 | Q14549 | |
| GLDSFSSGPGEEALL | 286 | O95393 | |
| GLSPAAHLGDGSSDL | 406 | Q8TCT0 | |
| SSTDSGSGGPLLFDD | 36 | Q9H0C8 | |
| AALGDAEGASPSSLG | 411 | Q8IYS4 | |
| QSEGGSGLDSSPFLS | 121 | Q96D53 | |
| AGDPASGVLASGDST | 141 | Q6VMQ6 | |
| ALSLIITADDGSGGP | 901 | O60307 | |
| GPGAAGTSSDALLAL | 771 | Q8TEH3 | |
| SSESLASDDGGAPGI | 91 | Q6NY19 | |
| LSAALLAPGGSSGRD | 46 | Q68CP4 | |
| ADVLSLSDGPPGAGS | 86 | O75629 | |
| APLLLDGSGSSLEGS | 371 | Q9Y6H8 | |
| LETLGSSEPAGGALR | 376 | Q96G97 | |
| DPITDSGSGAGAFLD | 336 | P39059 | |
| SDGSLLGDLGHTPLS | 11 | Q9Y2W7 | |
| DGPAGGLADLSSGSS | 371 | Q6NUJ5 | |
| LDTLGSEGALSPGGV | 986 | P0C0L4 | |
| PLSAAGDDSLGSDGD | 31 | Q9C009 | |
| PGLSAATLASLGGTS | 101 | Q32MZ4 | |
| LATPAGSAGGAVSEL | 566 | Q9UN75 | |
| GSPSEASGLGLDFED | 436 | Q504T8 | |
| FADSPLGCDLGASGL | 451 | Q96NZ1 | |
| ASLDSAGGSGSSPIL | 231 | Q9BST9 | |
| RAGPGLSTAGSLDLE | 1136 | A8K8P3 | |
| DSGAGLELGIASSPT | 21 | Q06945 | |
| ASELLPHTSSGGLGD | 106 | Q9BQS2 | |
| TDLLGDASPAFGSGS | 126 | Q9Y6A5 | |
| ASSAGGGLSPSDELL | 341 | Q8IW70 | |
| SPSAGPLSLAEGGAE | 611 | Q6ZMQ8 | |
| AAGGSAPELFTSLIG | 181 | Q9UI40 | |
| GGGLRSSESLPAAAE | 56 | O94761 | |
| PASAGGSAEALLSDL | 166 | Q14761 | |
| EATLLAPSTEAGGGL | 91 | O15446 | |
| LSTGGLPVASEDGAL | 26 | Q96GZ6 | |
| RLSSASSPGGLDAGL | 616 | Q8IXF0 | |
| DLAASVPAISGLGGS | 271 | P0DKV0 | |
| STESITGSLGPLLDG | 446 | P40967 | |
| QTAGESGSSPEGLLA | 816 | P98171 | |
| SSIESLSPGGDLFGL | 1566 | Q13023 | |
| LDSGPEGASVSSAGL | 1131 | Q8N2E2 | |
| SLSSVLGSGFGELAP | 351 | Q5T6F2 | |
| GPGEDGSLLGSSEIL | 261 | Q96SZ4 | |
| LLDAASDGSPLSESG | 411 | Q6ZU65 | |
| SGPAASSGLLGLATS | 2246 | Q9C0A1 | |
| GALLGSSDTGPQSGE | 1026 | Q8IWN7 | |
| PIGASLFASSEGSGL | 61 | A0PJK1 | |
| LGASSLGTPEDLAEG | 501 | Q9P2F5 | |
| SAGPITGLLDSLSGF | 271 | Q9BSJ1 | |
| SSTVADEPGALGSGA | 161 | Q96RF0 | |
| LGALSNDGSDDGPSV | 601 | O15014 | |
| LSGSGPAELSAGEDE | 466 | Q9BRR9 | |
| SLALSGGPSNEGTVL | 161 | O95758 | |
| SDPGLAGVSLTGGLS | 111 | P41273 | |
| RSLGDLPGGLEGSSA | 3181 | Q96JG9 | |
| AGPSAGAAGSSTLFL | 721 | Q9ULT6 | |
| GPAAGVGGLTDLSSL | 251 | Q96EQ0 | |
| GLENSSSGPGELLSH | 166 | P17022 | |
| SLDGSGPLTSLAVGD | 321 | Q8NA23 | |
| GRSLLESPGLTSGSD | 61 | P54821 | |
| GAGEGSPSATASILS | 146 | Q9NRR5 | |
| PALALLSASGTGSAA | 26 | O95185 | |
| LAETLEDTLAPGSGG | 311 | Q8TD43 | |
| SLPGAGLSSQELSGG | 816 | Q13263 | |
| SESGTAPDSTLGGAA | 146 | Q9UPQ9 | |
| LGLDSGELQSGPESS | 1081 | P49815 | |
| APGLSLGEGREAATS | 336 | Q9UNY4 | |
| DAVSVLGSGLGLSPG | 441 | Q9NW07 | |
| SFLGGGSSSGDPELA | 561 | Q5R3F8 | |
| GFLLPLSGGVDSAAT | 351 | Q6IA69 | |
| EDSESLGGASLGGLE | 1116 | O15399 |